Ignite Creation Date:
2024-05-05 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00290615
Status:
COMPLETED
Last Update Posted:
2013-05-07
First Post:
2006-02-09
Brief Title:
Capecitabine Cetuximab Oxaliplatin and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery
Sponsor:
Herbert Hurwitz
Organization:
Duke University
Organization Data
Organization:
Duke University
Class:
OTHER
Study ID:
Pro00007431 CDR0000449945
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Herbert Hurwitz
Lead Sponsor Class:
OTHER
Responsible Party:
Herbert Hurwitz
Responsible Party Title:
Associate Professor of Medicine
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Duke University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |